WHO ICTRP trial
A double blind, randomized, placebo controlled, cross-over trial investigating…
ACTRN12618000283279 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not recruiting
Key facts
| Trial ID | ACTRN12618000283279 |
|---|---|
| Public title | A double blind, randomized, placebo controlled, cross-over trial investigating the effect of High Amylose Maize Starch (HAMS) supplementation on fecal microbiological and inflammatory outcomes in individuals with Cystic Fibrosis and Healthy Volunteers. |
| Scientific title | A double blind, randomized, placebo controlled, cross-over trial investigating the effect of High Amylose Maize Starch (HAMS) supplementation on fecal microbiological and inflammatory outcomes in individuals with Cystic Fibrosis and Healthy Volunteers. |
| Primary sponsor | Mater Misericordiae Ltd |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Conditions | Cystic Fibrosis |
| Interventions | Participants will be asked to consume prepacked 40g/d high amylose maize starch (HAMS) or 40g/day regular maize starch (RMS - Placebo) in a cross over fashion. Participants will consume the investigational product for 2 weeks, followed by a… |
| Registration date | Feb 23, 2018 |
| Target size | 20 |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: